PAX5 and plasma cell myeloma: In the transcriptional study, we found that IRF4, an interferon regulatory factor and B-cell specific transcription factor, is a prognostic factor in multiple myeloma independent of patient age, ISS disease stage, levels of lactate dehydrogenase, and high risk factors.